Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

NCT01044485 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: lapatinib
DRUG: docetaxel

Sponsor

Centre Georges Francois Leclerc

Collaborators

[object Object]
[object Object]